PEP, or post-exposure
prophylaxis, is one-month medication regimens that may help people avoid
contracting HIV. Within 72 hours or 3 days of being exposed to a hazardous
physical relationship, you must begin PEP. It is best to begin PEP therapy as soon as possible.
PEP
medications must be taken at least twice daily for at least 28 days.
Antiretroviral medications are the names given to the drugs used in PEP (ART).
These drugs could aid in halting the transmission of HIV within your body.
Why is PEP treatment necessary?
Only PEP (post exposure
prophylaxis) medication can prevent HIV infection owing to potential
HIV exposure.
When should PEP treatment start?
Beginning PEP medication
within 72 hours of risky activity is recommended. This is the ideal time to
shield you from contracting HIV.
How long does it take to complete the PEP
medication course?
The pharmacological
regimen for PEP therapy must be finished in around 28–30 days.
Which procedures is a part of PEP
treatment?
The main techniques used
in PEP therapy include counseling, first aid care, testing, medication
regimens, and routine follow-ups.
What is the PEP treatment's success rate?
The effectiveness rate
of PEP treatment can reach 98 percent if it is begun within 72 hours of
engaging in risky sex.
Where is PEP Available?
HIV drugs are available all over India.
But Delhi's HIV Specialist Dr.
Vinod Raina is available 24*7 in Safe Hands Multispecialty STD clinic. Dr. Vinod Raina is a
well-known doctor for PEP
treatment in Delhi.
How to Reach Dr. Raina’s Safe Hands
Multispecialty STD clinic
India's famous Dr. Vinod Raina has been
in the post of CMO in Delhi's
Safdarjung Hospital. He has been treating patients suffering from HIV
for the last 22 years. You should get PEP
treatment in Delhi.
To reach Dr. Vinod Raina, you can contact him on
WhatsApp at his number +91-9136363692. You can also contact him at his
email address and on our official website:
https://www.pepforhivtreatment.com/
Call us at 9136363692 or 9871605858.
Watch our video: https://youtu.be/Vhi5liNsXME
.png)
No comments:
Post a Comment